- Qian, Xuyu;
- DeGennaro, Ellen;
- Talukdar, Maya;
- Akula, Shyam;
- Lai, Abbe;
- Shao, Diane;
- Gonzalez, Dilenny;
- Marciano, Jack;
- Smith, Richard;
- Hylton, Norma;
- Yang, Edward;
- Bazan, J;
- Barrett, Lee;
- Yeh, Rebecca;
- Hill, R;
- Beck, Samantha;
- Otani, Aoi;
- Angad, Jolly;
- Mitani, Tadahiro;
- Posey, Jennifer;
- Pehlivan, Davut;
- Calame, Daniel;
- Aydin, Hatip;
- Yesilbas, Osman;
- Parks, Kendall;
- England, Eleina;
- Im, Kiho;
- Taranath, Ajay;
- Scott, Hamish;
- Barnett, Christopher;
- Arts, Peer;
- Sherr, Elliott;
- Lupski, James;
- Walsh, Christopher;
- Argilli, Emanuela
Kinesins are canonical molecular motors but can also function as modulators of intracellular signaling. KIF26A, an unconventional kinesin that lacks motor activity, inhibits growth-factor-receptor-bound protein 2 (GRB2)- and focal adhesion kinase (FAK)-dependent signal transduction, but its functions in the brain have not been characterized. We report a patient cohort with biallelic loss-of-function variants in KIF26A, exhibiting a spectrum of congenital brain malformations. In the developing brain, KIF26A is preferentially expressed during early- and mid-gestation in excitatory neurons. Combining mice and human iPSC-derived organoid models, we discovered that loss of KIF26A causes excitatory neuron-specific defects in radial migration, localization, dendritic and axonal growth, and apoptosis, offering a convincing explanation of the disease etiology in patients. Single-cell RNA sequencing in KIF26A knockout organoids revealed transcriptional changes in MAPK, MYC, and E2F pathways. Our findings illustrate the pathogenesis of KIF26A loss-of-function variants and identify the surprising versatility of this non-motor kinesin.